Australia markets close in 5 hours 45 minutes

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.62+0.15 (+0.59%)
At close: 04:00PM EDT
25.74 +0.12 (+0.47%)
After hours: 06:43PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8101011
Avg. Estimate-0.89-0.9-3.27-3.06
Low estimate-1.08-1.1-5.21-5.14
High estimate-0.74-0.77-1.58-1.84
Year ago EPS-0.92-0.98-3.95-3.27
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4679
Avg. Estimate14.03M3.86M164.24M185.55M
Low estimateN/AN/A12.9M116.1M
High estimate52M15M459.78M256.97M
Year ago sales1.83MN/A9.3M164.24M
Sales growth (year/est)668.30%N/A1,665.50%13.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.83-0.83-0.82-0.91
Actual EPS-0.92-0.98-1.08-0.96
Difference-0.09-0.15-0.26-0.05
Surprise %-10.80%-18.10%-31.70%-5.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.89-0.9-3.27-3.06
7 days ago-0.92-0.94-3.25-3.03
30 days ago-0.92-0.94-3.25-3.03
60 days ago-0.91-1-3.62-3.26
90 days ago-0.96-0.97-3.47-3.12
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesBBIOIndustrySector(s)S&P 500
Current qtr.3.30%N/AN/AN/A
Next qtr.8.20%N/AN/AN/A
Current year17.20%N/AN/AN/A
Next year6.40%N/AN/AN/A
Next 5 years (per annum)67.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A